Jung Sil Ro

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Bilateral testicular germ cell tumors

Mingxin Che, Pheroze Tamboli, Jae Y. Ro et al. · Cancer · 2002 · 106 citations · Full text

Medicine, Oncology, Pathology +14

Randomized Pilot Test of a Simultaneous Stage-Matched Exercise and Diet Intervention for Breast Cancer Survivors

Soo Hyun Kim, Mi Soon Shin, Han Sul Lee et al. · Oncology nursing forum · 2011 · 81 citations · Full text

Medicine, Health Promotion, Nutrition +17

Health-Related Quality of Life in Survivors With Breast Cancer 1 Year After Diagnosis Compared With the General Population

Eun Sook Lee, Myung Kyung Lee, Soo Hyun Kim et al. · Annals of Surgery · 2010 · 80 citations

Medicine, Oncology, Breast Oncology +12

Clinical Characteristics of Malignant Pericardial Effusion Associated with Recurrence and Survival

Sung‐Hwan Kim, Mi Hyang Kwak, Sohee Park et al. · Cancer Research and Treatment · 2010 · 78 citations · Full text

Medicine, Oncology, Cardio-oncology +14